MedTrace Logo

Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer

NCT03727126 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-10-14

No results posted yet for this study

Summary

Esophageal cancer is a debilitating condition. The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases. Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival. Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable. It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy. The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus.

Conditions

  • Esophageal Cancer

Interventions

PROCEDURE

Robotic esophagectomy

Removal of the esophagus and its draining lymph nodes using robotic surgical instruments

PROCEDURE

Thoracolaparoscopic esophagectomy

Removal of the esophagus and its draining lymph nodes using conventional thoracoscopic and laparoscopic techniques

Sponsors & Collaborators

  • GEM Hospital & Research Center

    lead OTHER

Principal Investigators

  • Chinnusamy Palanivelu, MS, MCh · GEM Hospital & Research Center

  • Shankar Balasubramanian, MS, MRCS · GEM Hospital & Research Center

  • Sandeep Sabnis, MS, DNB · GEM Hospital & Research Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-12-31
Completion
2021-01-01

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03727126 on ClinicalTrials.gov